论文部分内容阅读
目的探讨心力衰竭(heart failure,HF)患者在常规治疗的同时服用倍他乐克的效果。方法选取2015年2月至2016年2月收治的HF患者64例,随机分为两组各32例,对照组按HF常规治疗方案,应用利尿剂、强心剂、ACEI药物等;观察组在此基础上同时服用倍他乐克缓释片,对比两组心率、血压、左室射血分数及临床疗效。结果观察组治疗后心率(74.72±5.82次/min)、左室射血分数(50.66±5.73)、SBP(126.84±9.63 mm Hg)、DBP(87.63±6.78 mm Hg)改善程度优于对照组(87.72±6.24次/min,43.87±4.86,139.72±12.83mm Hg,93.14±5.36 mm Hg)(P<0.05);观察组有效率(90.63%)高于对照组(71.88%)(P<0.05)。结论HF患者在常规治疗的同时服用倍他乐克能够改善心功能,提高治疗效果。
Objective To investigate the efficacy of metoprolol while taking conventional treatment in patients with heart failure (HF). Methods Sixty-four patients with HF who were admitted from February 2015 to February 2016 were randomly divided into two groups of 32 patients. The control group was treated with routine HF regimen and diuretic, cardiotonic, ACEI, At the same time taking metoprolol sustained-release tablets, compared two groups of heart rate, blood pressure, left ventricular ejection fraction and clinical efficacy. Results The improvement of heart rate (74.72 ± 5.82 beats / min), left ventricular ejection fraction (50.66 ± 5.73), SBP (126.84 ± 9.63 mm Hg) and DBP (87.63 ± 6.78 mm Hg) in the observation group was better than that of the control group 87.72 ± 6.24times / min, 43.87 ± 4.86,139.72 ± 12.83mm Hg, 93.14 ± 5.36 mm Hg) (P <0.05). The effective rate in the observation group (90.63%) was higher than that in the control group (71.88% . Conclusion HF patients taking Betaloc at the same time can improve heart function and improve the therapeutic effect.